Cite
HARVARD Citation
Devauchelle, V. et al. (n.d.). FRI0280 Efficacy and Safety of Tocilizumab as First Line Therapy in Patients with Recent Polymyalgia Rheumatica (PMR): Results of the First Longitudinal Prospective Study (Tenor). Annals of the rheumatic diseases. p. 526. [Online].